TARGETING HPV E6/E7 UPREGULATION OF THE TRANSMEMBRANE RECEPTOR TYROSINE KINASE ROR2 WITH THE ADC OZURIFTAMAB VEDOTIN IN PATIENTS WITH ADVANCED HPV+ OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

ozuriftamab vedotin (BA3021) - BioAtla

https://info.kenes.com/Flip/IPVC25_IPVC25/

Jacob Thomas1; Winston Wong2; Douglas Adkins3; Jamal Misleh4; Jochen Lorch5; Jaspreet Grewal6; Kathleen Kerrigan7; Jeffery Russell8; Jeremy Cetnar9; Kyechin Chen10; Kartik Aysola11; Bill Boyle10; Judith Llorin-Sangalang11; Eric Sievers10; Alan Ho2

Nov 6, 2025